IMIDAZO[1,2A]PYRIDINE ZUR BEHANDLUNG ODER PRÄVENTION VON HYPERURIKÄMIE ODER GICHT
European patent · EP3348557 · In force
Register entry
- Publication number
- EP3348557
- Application number
- EP16843670
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 8, 2016
- Published
- Jul 18, 2018
- Granted
- Apr 29, 2020
- Protection ends at the latest
- Sep 7, 2036
- Next annual fee due
- Sep 30, 2027
- IPC classes
- C07D 471/04 (2006.01)A61K 31/437 (2006.01)A61P 19/06 (2006.01)
- Priority
- CN 201510576110 10.09.2015
- PCT application
- PCT/CN2016/098468 08.09.2016
- PCT publication
- WO2017/041732 16.03.2017
- Filing language
- Chinese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Oct 31, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 31.10.2025
- Oct 4, 2024
Next annual fee due on
- Next annual fee due on
- 30.09.2024 → 30.09.2025
Published in Swissreg on 04.10.2024
- Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
- Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
- Jul 8, 2020
Agent entered
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 08.07.2020
- Apr 29, 2020
Granted
Published in Swissreg on 29.04.2020
Parties
Inventor
Zhenjiang Jiangsu 212009, CN
Zhenjiang Jiangsu 212009, CN
Zhenjiang Jiangsu 212009, CN
Zhenjiang Jiangsu 212009, CN
Zhenjiang Jiangsu 212009, CN
Zhenjiang Jiangsu 212009, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.